. 2022 Jan 17;355(5):2100382. doi: 10.1002/ardp.202100382
© 2022 Deutsche Pharmazeutische Gesellschaft
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
Scheme 23.
Synthesis of favipiravir